Prudential Financial’s Immunovant IMVT Stock Holding History

Prudential Financial’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$318K	Buy	+12,800	New	+$331K	﹤0.01%	2009
2024 Q2	–	Sell	-35,349	Closed	-$1.14M	–	2742
2024 Q1	$1.14M	Sell	35,349 -25,381	-42%	-$926K	﹤0.01%	1750
2023 Q4	$2.56M	Buy	60,730 +35,890	+144%	+$1.32M	﹤0.01%	1284
2023 Q3	$954K	Sell	24,840 -48,400	-66%	-$1.09M	﹤0.01%	1790
2023 Q2	$1.39M	Sell	73,240 -50,390	-41%	-$940K	﹤0.01%	1633
2023 Q1	$1.92M	Buy	123,630 +6,900	+6%	+$120K	﹤0.01%	1368
2022 Q4	$2.07M	Buy	116,730 +350	+0.3%	+$4.41K	﹤0.01%	1290
2022 Q3	$650K	Buy	+116,380	New	+$569K	﹤0.01%	1953
2021 Q2	–	Sell	-18,114	Closed	-$290K	–	2591
2021 Q1	$290K	Buy	18,114 +13,436	+287%	+$354K	﹤0.01%	2282
2020 Q4	$217K	Buy	+4,678	New	+$216K	﹤0.01%	2338

Other funds holding IMVT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Prudential Financial's IMVT Position: Q1 2026 in Review

Prudential Financial opened a new position in Immunovant (IMVT) in Q1 2026: 12,800 shares worth $318K. The stake represents ﹤0.01% of the portfolio and ranks #2009 among its holdings. This is a return to the name: Prudential Financial previously reported a position in IMVT as recently as Q1 2024.

Prudential Financial first reported a position in IMVT in Q4 2020 and has held it in 10 quarters since. The position peaked at $2.56M in Q4 2023. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

Prudential Financial held 12,800 shares of Immunovant worth $318K as of Q1 2026.
Immunovant was a new Prudential Financial position in Q1 2026.
Immunovant made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #2009 holding.
Prudential Financial first reported a position in Immunovant in Q4 2020 and has held it in 10 quarters since.
Prudential Financial's Immunovant position peaked at $2.56M in Q4 2023.
215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.